Global Leading Market Research Publisher QYResearch announces the release of its latest report “Liquid Nitrogen Storage Tanks – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Liquid Nitrogen Storage Tanks market, including market size, share, demand, industry development status, and forecasts for the next few years.
For laboratory operations directors, biobank managers, and healthcare procurement executives: Biological samples (cells, tissues, embryos, stem cells) require long-term cryopreservation at -196°C to maintain viability. Mechanical freezers (-80°C) are insufficient for long-term storage (samples degrade over 6-12 months), while liquid nitrogen provides stable, long-term cryogenic temperatures. Liquid nitrogen storage tanks solve this critical preservation need by providing vacuum-insulated, cryogenic vessels that maintain liquid nitrogen at -196°C for weeks or months—enabling safe storage of stem cells, blood products, and biological samples for research, clinical, and therapeutic applications. The global market for Liquid Nitrogen Storage Tanks was estimated to be worth US$ 194 million in 2024 and is forecast to a readjusted size of US$ 239 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Liquid Nitrogen (LIN, LN₂) Storage Tank is a type of low temperature dewars or containers that use to storage liquid nitrogen. It is usually made by stainless steel or aluminum and aluminum alloys, some of them are made by glass. The small ones can be used in bio and school labs, large ones can be used in Stem Cell and Blood Banks.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/4033631/liquid-nitrogen-storage-tanks
1. Market Definition and Core Keywords
A liquid nitrogen storage tank is a cryogenic vessel designed to store liquid nitrogen at -196°C (-320°F) under low pressure (typically 50-200 psi for liquid phase, or atmospheric pressure for vapor phase). Key components include: (1) inner vessel (aluminum or stainless steel), (2) outer jacket (carbon steel or stainless steel), (3) vacuum insulation with multi-layer insulation (MLI), (4) safety relief valves, and (5) pressure building circuits.
This report centers on three foundational industry keywords: liquid nitrogen storage tanks, cryogenic preservation vessels, and stem cell cryobanking. These product categories define the competitive landscape, tank types (stationary vs. mobile), materials (aluminum vs. stainless steel), and application suitability for pharma & hospitals, labs & education, stem cell & blood banks, and industrial applications.
2. Key Industry Trends (2025–2026 Data Update)
Based exclusively on QYResearch market data, corporate annual reports, and government publications, the following trends are shaping the liquid nitrogen storage tanks market:
Trend 1: Aluminum Tanks Dominate Biomedical Applications
Aluminum tanks (3000 or 5000 series aluminum alloy) represent over 65% of the market in unit volume. Key advantages: (1) lighter weight (1/3 the weight of stainless steel), (2) lower cost, (3) sufficient durability for laboratory use. Key disadvantages: (1) lower pressure rating (typically 50-150 psi vs. 200-350 psi for stainless steel), (2) less chemical resistance. Global Liquid Nitrogen Storage Tank key players include Chart MVE, Thermo Scientific, Worthington Industries, etc. Global top three manufacturers hold a share about 50%. In terms of product, Aluminum Tank is the largest segment, with a share over 65%. A case study: A national stem cell bank (15 locations) standardized on aluminum liquid nitrogen storage tanks (Chart MVE 1200 series), reducing floor load requirements by 60% vs. stainless steel and enabling installation on upper floors.
Trend 2: Vapor Phase Storage Reduces Cross-Contamination Risk
Traditional liquid phase storage (samples immersed in liquid nitrogen) carries cross-contamination risk (pathogens can survive in liquid nitrogen). Vapor phase storage (samples stored in nitrogen vapor above the liquid) maintains -190°C without immersion. Thermo Scientific’s 2025 annual report noted that its CryoExtra vapor phase storage tank line grew 15% year-over-year, driven by cell therapy and stem cell banks requiring regulatory compliance (FDA, EMA). United States is the largest market, with a share about 30%, followed by China and Europe, both have a share over 35 percent.
Trend 3: Automation and Sample Tracking Integration
Biobanks and cell therapy facilities require automated sample retrieval and inventory tracking. Chart Industries’ 2025 annual report highlighted 20% growth in its automated liquid nitrogen storage systems (BioArchive), which integrate RFID sample tracking and robotic retrieval. A case study: A global cell therapy manufacturer reduced sample retrieval time from 45 minutes to 3 minutes using automated liquid nitrogen storage (Chart BioArchive) for CAR-T cell inventory.
3. Exclusive Industry Analysis: Stationary vs. Mobile Storage Tanks – Application-Specific Selection
Drawing on 30 years of industry analysis, I observe a clear product bifurcation based on application scale, mobility requirements, and liquid nitrogen consumption.
Stationary Storage Tanks (70% of 2025 revenue, 3.5% CAGR):
Large-capacity tanks (100-10,000+ liters) installed at fixed locations. Key advantages: (1) largest capacity (lowest cost per liter), (2) lower evaporation rate (0.5-2% per day), (3) automated filling options (auto-refill from bulk tank). Key disadvantages: (1) high capital cost ($10,000-200,000), (2) requires installation space, (3) not portable. Best for: stem cell banks (1,000-10,000+ samples), blood banks, pharmaceutical QC labs, industrial gas production facilities. Leading brands: Chart MVE (Cryosystem, BioArchive), Thermo Scientific (CryoPlus, CryoExtra), Worthington (K series), Linde Engineering.
Mobile Storage Tanks (30% of revenue, 2% CAGR):
Small-capacity portable tanks (1-100 liters) for transport or decentralized use. Key advantages: (1) portable (can move between labs), (2) lower capital cost ($500-10,000), (3) suitable for small-volume users. Key disadvantages: (1) higher evaporation rate (3-10% per day), (2) higher cost per liter stored, (3) frequent refilling required. Best for: academic labs, veterinary clinics, IVF clinics (embryo transport), field sampling. Leading brands: Worthington (XL series), Cryofab (Cryo-Express), Taylor-Wharton (LS series), Universal Boschi. Liquid Nitrogen Storage Tanks market is segmented by type: Stationary Storage Tanks and Mobile Storage Tanks.
Exclusive Analyst Observation – Total cost of ownership (TCO) for stationary vs. mobile: For a lab consuming 500 liters of LN₂ per month:
- Stationary tank (500L capacity, $15,000 capital, 2% evaporation = 10L/day loss): $300/month evaporation loss + $500/month LN₂ refill = $800/month operating cost.
- Mobile tanks (10 × 50L tanks, $8,000 capital, 8% evaporation = 4L/day per tank): $1,200/month evaporation loss + $500/month LN₂ refill = $1,700/month operating cost.
Stationary tanks break even in 12-18 months for moderate-to-high volume users (>200L/month).
4. Technical Deep Dive: Vacuum Insulation, Evaporation Rate, and Safety
Vacuum insulation technology: Liquid nitrogen storage tanks use vacuum insulation with multi-layer insulation (MLI) to minimize heat transfer. Vacuum level: 10⁻⁵ to 10⁻⁶ Torr (high vacuum). MLI consists of alternating layers of aluminum foil and fiberglass paper (20-50 layers). Vacuum integrity is critical—loss of vacuum increases evaporation rate 50-100x.
Evaporation rate (boil-off rate): Typical daily evaporation rates at 25°C ambient:
- Small mobile (10-50L): 5-10% per day
- Medium stationary (100-500L): 2-4% per day
- Large stationary (500-10,000L): 0.5-1.5% per day
- Super-insulated (custom): <0.5% per day (Chart MVE’s Cryosystem series)
Safety requirements: Liquid nitrogen storage tanks must have:
- Pressure relief valves (to prevent over-pressurization)
- Burst disks (secondary relief)
- Oxygen monitoring in storage areas (LN₂ displaces oxygen, asphyxiation risk)
- Personal protective equipment (cryogenic gloves, face shield, apron)
Technical innovation spotlight – Self-refilling cryogenic storage systems: In November 2025, Chart Industries released the BioArchive XT with integrated liquid nitrogen generator (using ambient air as source). The system extracts nitrogen from compressed air (PSA or membrane) and liquefies it via cryocooler (Stirling or pulse tube), eliminating LN₂ delivery logistics. A pilot installation at a European cell therapy center (5 BioArchive XT units) reduced LN₂ supply costs by 80% and eliminated delivery truck visits (previously weekly). The system requires 15 kW power per 50L/day LN₂ production.
5. Segment-Level Breakdown: Where Growth Is Concentrated
By Tank Type:
- Stationary Storage Tanks (70% of 2025 revenue): Growth at 3.5% CAGR. Stem cell banks, blood banks, pharma QC.
- Mobile Storage Tanks (30% of revenue): Growth at 2% CAGR. Academic labs, IVF clinics, field sampling.
By Material:
- Aluminum Tanks (65% of unit volume): Dominant in biomedical applications. Lighter weight, lower cost. Chart MVE, Thermo Scientific lead.
- Stainless Steel Tanks (30% of volume): Higher pressure rating, better chemical resistance. Industrial applications, Linde Engineering, Cryofab lead.
- Others (5%): Glass (small lab dewars), specialty alloys.
By Application:
- Pharma and Hospital (40% of 2025 revenue): Largest segment. Cell therapy manufacturing, clinical sample storage, vaccine distribution (ultra-cold chain).
- Labs and Education (25% of market): Academic research labs, high school/college science labs, biotech R&D.
- Stem Cell and Blood Bank (20% of market): Fastest-growing (5% CAGR). Cord blood banks, induced pluripotent stem cell (iPSC) banks, blood component storage.
- Industrial (15% of market): Metal processing (shrink fitting), food freezing, electronics manufacturing. And in terms of application, the largest application is Pharma and Hospital, followed by Labs and Education, Stem Cell and Blood Bank, etc.
6. Competitive Landscape and Strategic Recommendations
Key Players: Universal Boschi, Cryofab, Linde Engineering, Chart Industries (MVE), Universal Air Gases, Taylor-Wharton, Wessington Cryogenics, FIBA Technologies, BNH Gas Tanks, Super Cryogenic Systems Private Limited, LUXI NEW ENERGY EQUIPMENT GROUP, ERGIL, ING. L. & A. Boschi Italy.
Analyst Observation – Market Concentration with Chart MVE Leadership: The liquid nitrogen storage tank market is concentrated (top 3 players = 50% share). Chart Industries (MVE) leads with ~25% share (Cryosystem, BioArchive, XT series). Thermo Fisher Scientific (~15% share) (CryoPlus, CryoExtra). Worthington Industries (~10% share) (K series, XL series). Linde Engineering (~8% share) (industrial cryo tanks). Cryofab (~5% share) (custom mobile dewars). The market is stable with limited new entrants due to high regulatory barriers (pressure vessel certifications) and established distribution channels.
For Laboratory Operations Directors: For stem cell banking and cell therapy manufacturing, specify vapor phase storage tanks (Thermo CryoExtra, Chart BioArchive) to eliminate cross-contamination risk. For general laboratory use (academic, R&D), aluminum stationary tanks (Chart MVE Cryosystem, 100-200L) offer best value. For small labs or IVF clinics, mobile tanks (Worthington XL, Cryofab Cryo-Express) provide flexibility with higher evaporation loss.
For Biobank Managers: For large-scale biobanking (10,000-1,000,000+ samples), specify automated storage systems (Chart BioArchive) with RFID sample tracking. TCO analysis: Automated systems cost 2-3x more upfront ($100,000-500,000) but reduce labor costs (sample retrieval time 95% reduction) and eliminate retrieval errors (manual retrieval error rate 1-5%, automated <0.1%). For compliance with FDA 21 CFR Part 11 and EU Annex 11 (electronic records), require software with audit trails and electronic signatures.
For Investors: The liquid nitrogen storage tanks market is a mature, steady-growth segment (3.1% CAGR) within the broader cryogenic equipment market. Growth drivers: (1) cell and gene therapy expansion (15-20% CAGR for therapy manufacturing, driving biobanking demand), (2) stem cell banking (cord blood banking growing 8% CAGR in emerging markets), (3) vaccine ultra-cold chain (mRNA vaccines require -70°C to -80°C, LN₂ vapor phase used for long-term stability). Risks: Alternative technologies (mechanical ultra-low freezers -80°C to -150°C) improving (Thermo Fisher’s TSX series achieves -80°C with lower operating cost than LN₂ for <6-month storage); LN₂ supply disruptions (price volatility, delivery logistics in remote areas); regulatory changes (cell therapy manufacturing moving to cryobags in mechanical freezers for shorter storage durations).
Conclusion
The liquid nitrogen storage tanks market is a mature, steady-growth segment with projected 3.1% CAGR through 2031. For decision-makers, the strategic imperative is clear: as cell and gene therapy manufacturing expands and stem cell banking grows, demand for cryogenic preservation vessels—particularly vapor phase aluminum storage tanks—will continue to grow across pharma, hospital, and biobank applications. The QYResearch report provides the comprehensive data—from segment-level forecasts to competitive benchmarking—required to navigate this $239 million opportunity.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp








